Anticonvulsants for alcohol withdrawal (Q24236686)

4

0 references

Laura Amato

2

0 references

Simona Vecchi

3

0 references

Silvia Minozzi

Cochrane Database of Systematic Reviews

1

0 references

publication date

17 March 2010

0 references

published in

0 references

cites work

Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre doubl-blind comparison with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Gabapentin's acute effect on mood profile -- a controlled study on patients with alcohol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Clinical conditions and central dopamine metabolism in alcoholics during acute withdrawal under treatment with different pharmacological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Emergency department treatment of alcohol withdrawal seizures with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Comparative Evaluation of Treatments of Alcohol Withdrawal Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Delirium tremens: a double-blind comparison of diazepam and barbital treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Diphenylhydantoin control of alcohol withdrawal seizures. Results of a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Efficacy of acamprosate in the treatment of alcohol-dependent outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

The use of divalproex in alcohol relapse prevention: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Intrathecal and oral clonidine as prophylaxis for postoperative alcohol withdrawal syndrome: a randomized double-blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Inpatient desire to drink as a predictor of relapse to alcohol use following treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Investigation of the abuse liability of buspirone in alcohol-dependent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Clinical physiological study of the therapeutic effects of phenytoin in acute alcohol withdrawal and the asthenic-autonomic syndrome in patients with chronic alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Acupuncture in the treatment of alcohol withdrawal symptoms: a randomized, placebo‐controlled inpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Barbital and diazepam plasma levels during treatment of delirium tremens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Randomized clinical trial of atenolol in patients with alcohol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

A Comparison of the Efficacy and Tolerability of Clobazam and Chlordiazepoxide in the Treatment of Acute Withdrawal from Alcohol in Patients with Primary Alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Trends in the management of alcohol withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Adjuvant drug treatment of alcoholism with acamprosate: between sectoral budgets and disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Relapse prevention in alcoholics with an anticraving drug treatment: first results of the Berlin Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Changes in EEG, blood levels, mood scales and performance scores during long term treatment with diazepam, phenobarbital or placebo in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Finnish Experiences with Carbamazepine (Tegretol ®) in the Treatment of Acute Withdrawal Symptoms in Alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Prophylaxis of alcohol withdrawal syndrome in alcohol-dependent patients admitted to the intensive care unit after tumour resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Topiramate for the treatment of alcohol dependence: initiating abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Benzodiazepines for alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Alcohol and withdrawal: from animal research to clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Glutamate-mediated transmission, alcohol, and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Acamprosate for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Psychotropic analgesic nitrous oxide for alcoholic withdrawal states

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Ethanol and negative feedback regulation of mesolimbic dopamine release in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Drug abuse: hedonic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Alcohol and the brain. Pharmacological insights for psychiatrists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Anticonvulsants for alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Magnesium for alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

The glutamatergic basis of human alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Oxcarbazepine at High Dosages for the Treatment of Alcohol Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Divalproex in the Treatment of Alcohol Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Retardiertes Carbamazepin in der Therapie des alkoholischen Prädelirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Reduction in early alcohol abstinence fits by administration of carbamazepine syrup instead of tablets

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Alpha-2-adrenoceptor sensitivity in early alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Controlled trial of acupuncture for severe recidivist alcoholism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Autonomic reactivity to mental stressors after single administration of lorazepam in male alcoholics and healthy controls

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Post-detoxification drug treatment of anxiety and depression in alcohol addicts.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

A comparison of three approaches to alcohol-withdrawal states

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Alprazolam versus chlormethiazole in acute alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Is clonidine useful in the treatment of alcohol withdrawal?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

A placebo-controlled trial of buspirone in anxious inpatient alcoholics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Fluoxetine Treatment Seems to Reduce the Beneficial Effects of Cognitive-Behavioral Therapy in Type B Alcoholics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Evaluation of chlormethiazole in treatment for alcohol withdrawal syndrome. Results of a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Experience with three drugs in ambulatory treatment of alcohol patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Treatment of alcohol withdrawal symptoms in hospitalized patients. A randomized, double-blind comparison of carbamazepine (Tegretol) and barbital (Diemal)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Controlled trial of chlormethiazole in treatment of the alcoholic withdrawal phase

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Comparison of chlormethiazole (Heminevrin) and chlordiazepoxide (Librium) in the treatment of acute alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Calcium-channel-blocking agent in the treatment of acute alcohol withdrawal--caroverine versus meprobamate in a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Prevention of Alcohol Withdrawal Seizures: The Roles of Diphenylhydantoin and Chlordiazepoxide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

The natural history of alcohol abuse: implications for definitions of alcohol use disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Chlormethiazole and trifluoperazine in alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Tiapride in the prevention of relapse in recently detoxified alcoholics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021

Sodium valproate in the treatment of the alcohol withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB3

7 January 2021